![Frontiers | Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice Frontiers | Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice](https://www.frontiersin.org/files/Articles/662714/fcimb-11-662714-HTML-r1/image_m/fcimb-11-662714-g001.jpg)
Frontiers | Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice
![Experiments Investigating the Competitive Growth Advantage of Two Different Genotypes of Human Metapneumovirus: Implications for the Alternation of Genotype Prevalence | Scientific Reports Experiments Investigating the Competitive Growth Advantage of Two Different Genotypes of Human Metapneumovirus: Implications for the Alternation of Genotype Prevalence | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-020-59150-9/MediaObjects/41598_2020_59150_Fig1_HTML.png)
Experiments Investigating the Competitive Growth Advantage of Two Different Genotypes of Human Metapneumovirus: Implications for the Alternation of Genotype Prevalence | Scientific Reports
![Human Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children | NEJM Human Metapneumovirus and Lower Respiratory Tract Disease in Otherwise Healthy Infants and Children | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/2004/nejm_2004.350.issue-5/nejmoa025472/production/images/img_medium/nejmoa025472_f3.jpeg)